pharmaceutical manufacturer
S.1720, Patent Transparency and Improvements Act of 2013 FDA policy
CPT - Copyright/Patent/Trademark HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
GEPHARDT GROUP GOVERNMENT AFFAIRS
1667 K ST NW, Suite 800, Washington, DC, 20006, US
JANICE O'CONNELL JANICE O'CONNELL